Cargando…

Rapid elimination of cervical cancer while maintaining the harms and benefits ratio of cervical cancer screening: a modelling study

BACKGROUND: Human papillomavirus (HPV) vaccination and intensifying screening expedite cervical cancer (CC) elimination, yet also deteriorate the balance between harms and benefits of screening. We aimed to find screening strategies that eliminate CC rapidly but maintain an acceptable harms-benefits...

Descripción completa

Detalles Bibliográficos
Autores principales: Jansen, Erik E. L., de Kok, Inge M. C. M., Kaljouw, Sylvia, Demirel, Erhan, de Koning, Harry J., Hontelez, Jan. A. C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9645325/
https://www.ncbi.nlm.nih.gov/pubmed/36352410
http://dx.doi.org/10.1186/s12916-022-02631-7
_version_ 1784826942386601984
author Jansen, Erik E. L.
de Kok, Inge M. C. M.
Kaljouw, Sylvia
Demirel, Erhan
de Koning, Harry J.
Hontelez, Jan. A. C.
author_facet Jansen, Erik E. L.
de Kok, Inge M. C. M.
Kaljouw, Sylvia
Demirel, Erhan
de Koning, Harry J.
Hontelez, Jan. A. C.
author_sort Jansen, Erik E. L.
collection PubMed
description BACKGROUND: Human papillomavirus (HPV) vaccination and intensifying screening expedite cervical cancer (CC) elimination, yet also deteriorate the balance between harms and benefits of screening. We aimed to find screening strategies that eliminate CC rapidly but maintain an acceptable harms-benefits ratio of screening. METHODS: Two microsimulation models (STDSIM and MISCAN) were applied to simulate HPV transmission and CC screening for the Dutch female population between 2022 and 2100. We estimated the CC elimination year and harms-benefits ratios of screening for 228 unique scenarios varying in vaccination (coverage and vaccine type) and screening (coverage and number of lifetime invitations in vaccinated cohorts). The acceptable harms-benefits ratio was defined as the number of women needed to refer (NNR) to prevent one CC death under the current programme for unvaccinated cohorts (82.17). RESULTS: Under current vaccination conditions (bivalent vaccine, 55% coverage in girls, 27.5% coverage in boys), maintaining current screening conditions is projected to eliminate CC by 2042, but increases the present NNR with 41%. Reducing the number of lifetime screens from presently five to three and increasing screening coverage (61% to 70%) would prevent an increase in harms and only delay elimination by 1 year. Scaling vaccination coverage to 90% in boys and girls with the nonavalent vaccine is estimated to eliminate CC by 2040 under current screening conditions, but exceeds the acceptable NNR with 23%. Here, changing from five to two lifetime screens would keep the NNR acceptable without delaying CC elimination. CONCLUSIONS: De-intensifying CC screening in vaccinated cohorts leads to little or no delay in CC elimination while it substantially reduces the harms of screening. Therefore, de-intensifying CC screening in vaccinated cohorts should be considered to ensure acceptable harms-benefits ratios on the road to CC elimination. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12916-022-02631-7.
format Online
Article
Text
id pubmed-9645325
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-96453252022-11-14 Rapid elimination of cervical cancer while maintaining the harms and benefits ratio of cervical cancer screening: a modelling study Jansen, Erik E. L. de Kok, Inge M. C. M. Kaljouw, Sylvia Demirel, Erhan de Koning, Harry J. Hontelez, Jan. A. C. BMC Med Research Article BACKGROUND: Human papillomavirus (HPV) vaccination and intensifying screening expedite cervical cancer (CC) elimination, yet also deteriorate the balance between harms and benefits of screening. We aimed to find screening strategies that eliminate CC rapidly but maintain an acceptable harms-benefits ratio of screening. METHODS: Two microsimulation models (STDSIM and MISCAN) were applied to simulate HPV transmission and CC screening for the Dutch female population between 2022 and 2100. We estimated the CC elimination year and harms-benefits ratios of screening for 228 unique scenarios varying in vaccination (coverage and vaccine type) and screening (coverage and number of lifetime invitations in vaccinated cohorts). The acceptable harms-benefits ratio was defined as the number of women needed to refer (NNR) to prevent one CC death under the current programme for unvaccinated cohorts (82.17). RESULTS: Under current vaccination conditions (bivalent vaccine, 55% coverage in girls, 27.5% coverage in boys), maintaining current screening conditions is projected to eliminate CC by 2042, but increases the present NNR with 41%. Reducing the number of lifetime screens from presently five to three and increasing screening coverage (61% to 70%) would prevent an increase in harms and only delay elimination by 1 year. Scaling vaccination coverage to 90% in boys and girls with the nonavalent vaccine is estimated to eliminate CC by 2040 under current screening conditions, but exceeds the acceptable NNR with 23%. Here, changing from five to two lifetime screens would keep the NNR acceptable without delaying CC elimination. CONCLUSIONS: De-intensifying CC screening in vaccinated cohorts leads to little or no delay in CC elimination while it substantially reduces the harms of screening. Therefore, de-intensifying CC screening in vaccinated cohorts should be considered to ensure acceptable harms-benefits ratios on the road to CC elimination. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12916-022-02631-7. BioMed Central 2022-11-09 /pmc/articles/PMC9645325/ /pubmed/36352410 http://dx.doi.org/10.1186/s12916-022-02631-7 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Jansen, Erik E. L.
de Kok, Inge M. C. M.
Kaljouw, Sylvia
Demirel, Erhan
de Koning, Harry J.
Hontelez, Jan. A. C.
Rapid elimination of cervical cancer while maintaining the harms and benefits ratio of cervical cancer screening: a modelling study
title Rapid elimination of cervical cancer while maintaining the harms and benefits ratio of cervical cancer screening: a modelling study
title_full Rapid elimination of cervical cancer while maintaining the harms and benefits ratio of cervical cancer screening: a modelling study
title_fullStr Rapid elimination of cervical cancer while maintaining the harms and benefits ratio of cervical cancer screening: a modelling study
title_full_unstemmed Rapid elimination of cervical cancer while maintaining the harms and benefits ratio of cervical cancer screening: a modelling study
title_short Rapid elimination of cervical cancer while maintaining the harms and benefits ratio of cervical cancer screening: a modelling study
title_sort rapid elimination of cervical cancer while maintaining the harms and benefits ratio of cervical cancer screening: a modelling study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9645325/
https://www.ncbi.nlm.nih.gov/pubmed/36352410
http://dx.doi.org/10.1186/s12916-022-02631-7
work_keys_str_mv AT jansenerikel rapideliminationofcervicalcancerwhilemaintainingtheharmsandbenefitsratioofcervicalcancerscreeningamodellingstudy
AT dekokingemcm rapideliminationofcervicalcancerwhilemaintainingtheharmsandbenefitsratioofcervicalcancerscreeningamodellingstudy
AT kaljouwsylvia rapideliminationofcervicalcancerwhilemaintainingtheharmsandbenefitsratioofcervicalcancerscreeningamodellingstudy
AT demirelerhan rapideliminationofcervicalcancerwhilemaintainingtheharmsandbenefitsratioofcervicalcancerscreeningamodellingstudy
AT dekoningharryj rapideliminationofcervicalcancerwhilemaintainingtheharmsandbenefitsratioofcervicalcancerscreeningamodellingstudy
AT hontelezjanac rapideliminationofcervicalcancerwhilemaintainingtheharmsandbenefitsratioofcervicalcancerscreeningamodellingstudy